This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Statement of Retraction: MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOcular Oncology and Treatments · Ocular Disorders and Treatments · Microtubule and mitosis dynamics
We, the Editors and Publisher of the journal Bioengineered, have retracted the following article from publication.
Lei, P., Xue, L., Wu, Y., & Zhong, J. (2022). MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification. Bioengineered, 13(7–12), 15033–15044. https://doi.org/10.1080/21655979.2023.2184317
Since publication, significant concerns have been raised about the integrity of the data and reported results in the article.
When approached for an explanation, the authors provided their original data and answered our queries, but these do not sufficiently address the concerns.
As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors have been informed of this decision. The authors do not agree with the retraction.
We have been informed in our decision-making by our policy on publishing ethics and integrity and COPE guidelines.
The retracted article will remain online to maintain the scholarly record and will be digitally watermarked on each page as ‘Retracted’.